Aditya Birla Sun Life Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹704 Cr | ₹949 Cr |
| Min Investment | ₹1000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jul 2019 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 31% | 26.49% |
| Expense Ratio | 2.37 | 2.21 |
| Manager | Dhaval Joshi | Meeta Shetty |
| ISIN Code | INF209KB1N91 | INF277K016A9 |
| Exits Load | Exit load of 1% if redeemed within 30 days./365 | Exit load of 0.25% if redeemed within 30 days./365 |
| Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 5.81% | 7.23% |
| 6 Month | 18.62% | 21.76% |
| 1 Year | 52.25% | 52.93% |
| 3 Year | 17.32% | 19.75% |
| 5 Year | 25.87% | 28.8% |
| Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 17.07% | 17.22% |
| 3 Year | 41.28% | 42.6% |
| 5 Year | 69.6% | 77.31% |
| Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 28.48% | 6.62% |
| 3 Year | 15.06% | 17.45% |
| 5 Year | 25.33% | 14.18% |
| Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.83% | 14.23% |
| Sharp | 0.61% | 0.74% |
| Beta | 0.96% | 0.9% |
| Alpha | 0.67% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Dhaval Joshi | Meeta Shetty |
| Total AUM | ₹361932 Cr | ₹17847 Cr |
| Fund Manage | 55 | 5 |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 7.99 | 5.34 |
| Large Cap | 41.75 | 38.65 |
| Mid Cap | 31.34 | 39.68 |
| Small Cap | 18.91 | 16.33 |
| Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 7.99 | 3.05 |
| Pharmaceuticals & Biotechnology | 71.97 | - |
| Healthcare Services | 15.51 | - |
| Chemicals & Petrochemicals | 0.91 | - |
| Insurance | 3.61 | - |
| Healthcare | - | 93.35 |
| Chemicals | - | 1.31 |
| Services | - | 2.29 |
Top Comparisons
SBI Multi Asset Allocation Fund - Regular Plan - Growth
3Y Returns15.6%
Mirae Asset Multi Asset Allocation Fund-Reg (G)
3Y Returns0%
Tata Equity PE Fund Regular Plan -(Growth Option)
3Y Returns21.16%
Quant Value Fund Regular - Growth
3Y Returns0%
SBI International Access - US Equity FoF - Regular Plan - Growth
3Y Returns12.29%
Sundaram Global Brand Fund Regular Plan - Growth
3Y Returns6.7%
BANDHAN Large Cap Fund - Regular Plan - Growth
3Y Returns17.66%
Aditya Birla Sun Life Frontline Equity Fund-Growth
3Y Returns13.8%